SEC Form 4 · accession 0001144204-15-072687
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven S Myers
Director · Other
Period of report
Dec 22, 2015
Accepted (ET)
Dec 23, 2015 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1 | Dec 22, 2015 | A | 150,000 | $0.00 | A | 302,931 | D | |
| Common stock, par value $0.001 per share | holding | — | — | — | 84,331 | I | By Steven S. Myers IRA | |
| Common stock, par value $0.001 per share | holding | — | — | — | 8,012 | I | By Spouse | |
| Common stock, par value $0.001 per share | holding | — | — | — | 19,531 | I | By Steven S. Myers Revocable Trust dated 12/1/2000 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 22, 2015 (the "Grant Date"), the Reporting Person was granted an award of 150,000 shares of the Company's common stock (the "Shares"), subject to all of the terms and conditions of the Company's 2015 Equity Compensation Plan (the "Plan"). The Shares vest as to 50,000 shares upon the Grant Date and 25,000 shares per quarter on the last day of each quarter, commencing March 31, 2016, so long as he remains Chairman, until fully vested.
Remarks
Interim Chairman of the Board of Directors